Cargando…
Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
Thymidine incorporation in vitro by remission lymphocytes from a total of 6 patients with acute myeloid leukaemia (AML) was measured following stimulation by autochthonous and allogeneic AML blasts and cell lines. The early peak response to autochthonous blasts in 2 of these patients (48-72 h) is co...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1976
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024968/ https://www.ncbi.nlm.nih.gov/pubmed/1064430 |
_version_ | 1782136668068773888 |
---|---|
author | Taylor, G. M. Freeman, C. B. Harris, R. |
author_facet | Taylor, G. M. Freeman, C. B. Harris, R. |
author_sort | Taylor, G. M. |
collection | PubMed |
description | Thymidine incorporation in vitro by remission lymphocytes from a total of 6 patients with acute myeloid leukaemia (AML) was measured following stimulation by autochthonous and allogeneic AML blasts and cell lines. The early peak response to autochthonous blasts in 2 of these patients (48-72 h) is consistent with the concept of a population of lymphocytes pre-immunized to antigens carried by the blasts. Although stimulation in one patient was increased in the presence of more stimulating (S) blasts than responding (R) lymphocytes, positive responses in other tests were obtained at an S : R ratio of 1 : 1-5. When different methods of treatment of the stimulating autochthonous blasts were compared with untreated cells, mitomycin C gave the highest stimulation indices 2 out of 3 tests. Tissue culture medium in which autochthonous blasts had been incubated for 3-5 days failed to stimulate either remission lymphocytes alone, or combined cultures of lymphocytes with autochthonous or allogeneic blasts, suggesting that mitogenic factors released from autochthonous blasts are not responsible for lymphocyte stimulation. Treatment of autochthonous or allogeneic AML blasts with glycine-HC1(pH 3-0) to remove putative "blocking" factors failed to increase the stimulatory capacity of the leukaemic blasts. |
format | Text |
id | pubmed-2024968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1976 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20249682009-09-10 Response of remission lymphocytes to autochthonous leukaemic myeloblasts. Taylor, G. M. Freeman, C. B. Harris, R. Br J Cancer Research Article Thymidine incorporation in vitro by remission lymphocytes from a total of 6 patients with acute myeloid leukaemia (AML) was measured following stimulation by autochthonous and allogeneic AML blasts and cell lines. The early peak response to autochthonous blasts in 2 of these patients (48-72 h) is consistent with the concept of a population of lymphocytes pre-immunized to antigens carried by the blasts. Although stimulation in one patient was increased in the presence of more stimulating (S) blasts than responding (R) lymphocytes, positive responses in other tests were obtained at an S : R ratio of 1 : 1-5. When different methods of treatment of the stimulating autochthonous blasts were compared with untreated cells, mitomycin C gave the highest stimulation indices 2 out of 3 tests. Tissue culture medium in which autochthonous blasts had been incubated for 3-5 days failed to stimulate either remission lymphocytes alone, or combined cultures of lymphocytes with autochthonous or allogeneic blasts, suggesting that mitogenic factors released from autochthonous blasts are not responsible for lymphocyte stimulation. Treatment of autochthonous or allogeneic AML blasts with glycine-HC1(pH 3-0) to remove putative "blocking" factors failed to increase the stimulatory capacity of the leukaemic blasts. Nature Publishing Group 1976-05 /pmc/articles/PMC2024968/ /pubmed/1064430 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Taylor, G. M. Freeman, C. B. Harris, R. Response of remission lymphocytes to autochthonous leukaemic myeloblasts. |
title | Response of remission lymphocytes to autochthonous leukaemic myeloblasts. |
title_full | Response of remission lymphocytes to autochthonous leukaemic myeloblasts. |
title_fullStr | Response of remission lymphocytes to autochthonous leukaemic myeloblasts. |
title_full_unstemmed | Response of remission lymphocytes to autochthonous leukaemic myeloblasts. |
title_short | Response of remission lymphocytes to autochthonous leukaemic myeloblasts. |
title_sort | response of remission lymphocytes to autochthonous leukaemic myeloblasts. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024968/ https://www.ncbi.nlm.nih.gov/pubmed/1064430 |
work_keys_str_mv | AT taylorgm responseofremissionlymphocytestoautochthonousleukaemicmyeloblasts AT freemancb responseofremissionlymphocytestoautochthonousleukaemicmyeloblasts AT harrisr responseofremissionlymphocytestoautochthonousleukaemicmyeloblasts |